A full study testing dexamethasone — a cheap, widely available steroid — as a treatment for COVID-19 found that the drug reduced mortality rates among patients on ventilators or who were receiving ...

Intravitreal dexamethasone implants stabilized, but did not improve, vision for most patients with macular edema due to retinal vein occlusion (RVO). Intravitreal dexamethasone implants were found to ...

A dexamethasone-sparing regimen involving lenalidomide (Revlimid) and the anti-CD38 drug daratumumab (Darzalex) was safe and effective in older, frail patients with newly diagnosed multiple myeloma, ...

The drug is cheap and widely available, meaning it can be rolled out quickly to poorer communities hit by the disease. Researchers from Oxford University announced that the drug dexamethasone can cut ...

As the coronavirus continues to spread around the globe, companies and academic labs are racing to develop a vaccine that would help society get back to normal. But there could also be costs to moving ...

A British trial showing that a common steroid could reduce deaths in severe COVID-19 cases by one-third was good news for Minnesota physicians who have been battling the infectious disease without a ...

A paper published Friday in the New England Journal of Medicine suggests a low-cost steroid may be a valuable treatment for severe COVID-19, building upon encouraging preliminary findings from last ...

COVID-19 patients who took the anti-inflammatory steroid dexamethasone while hooked up to oxygen at a hospital had “significantly reduced” odds of dying there or going into hospice care, a study has ...

Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (WHNT) – Dexamethasone, a widely available ...

A dexamethasone-sparing regimen of daratumumab and lenalidomide was safe and effective in older, frail patients with newly diagnosed multiple myeloma. Among that select group of patients, ...